Therefore, it would be of interest to monitor the immunological status, such as routine detection of antinuclear and myelin basic protein and myelin oligodendrocyte auto-antibodies to demonstrate efficacy of sirolimus in patients with ALD. This evidence concerns the gene MBP and X-linked adrenoleukodystrophy.